Related Experiment Video

Updated: Mar 30, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

8.2K

New Frontiers for the NFIL3 bZIP Transcription Factor in Cancer, Metabolism and Beyond

Megan Keniry1, Robert K Dearth1, Michael Persans1

  • 1Department of Biology, University of Texas- Pan American, 1201 W. University Dr., Edinburg, TX 78539, USA.

Discoveries (Craiova, Romania)
|November 6, 2015
PubMed

Insights

Nuclear factor Interleukin 3 regulated (NFIL3) impacts circadian rhythm, cellular viability, and immunity. This review explores NFIL3’s role in gene regulation, focusing on CEBPβ and FOXO1 pathways in disease.

Area of Science:

  • Molecular Biology
  • Immunology
  • Genetics

Background:

  • The bZIP transcription factor NFIL3, also known as E4BP4, regulates fundamental biological processes.
  • Emerging research highlights NFIL3's involvement in immunity, cancer, aging, and metabolism.
  • Understanding NFIL3's regulatory mechanisms is crucial for disease research.

Purpose of the Study:

  • To review recent advances in NFIL3-mediated transcriptional regulation.
  • To elucidate NFIL3's impact on signaling pathways and gene activation.
  • To highlight NFIL3's role in physiological and pathological processes.

Main Methods:

  • Literature review of recent studies on NFIL3.
  • Analysis of NFIL3's transcriptional targets, including CEBPβ and FOXO1.
  • Discussion of NFIL3's role in signal transduction.

Main Results:

  • NFIL3 regulates a diverse set of genes involved in circadian rhythm and cellular viability.
  • NFIL3 plays significant roles in immunological signal transduction.
  • NFIL3 is implicated in the pathogenesis of cancer, aging, and metabolic disorders.

Conclusions:

  • NFIL3 is a key regulator with broad physiological and pathological implications.
  • Further research into NFIL3-mediated pathways will enhance understanding of disease.
  • NFIL3 represents a potential therapeutic target for various conditions.
Keywords:
CEBPβCancerImmunologyMetabolismNFIL3

More Related Videos

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.4K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K